Year archive

MicroPort NeuroScientic Corporation — 2026 filings

All 23 regulatory filings released by MicroPort NeuroScientic Corporation (2172) in 2026, sourced directly from the official regulator.

23 Filings

2026 Period

2026 filings (23)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - NUMEN Helia COIL RECEIVES APPROVAL FROM FDA FOR MARKETING Regulatory Filings	2026-05-25	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-14	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-13	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-12	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 3 JUNE 2026 AGM Information	2026-05-06	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2026-05-06	English
SCRIP DIVIDEND IN RELATION TO THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025; PROPOSED RE-ELECTION OF DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITORS; PROPOSED GRANTING OF GENERAL MANDATES TO B AGM Information	2026-05-06	English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-06	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-05	English
Next Day Disclosure Return Transaction in Own Shares	2026-04-30	English
Next Day Disclosure Return Transaction in Own Shares	2026-04-29	English
CLOSURE OF REGISTER OF MEMBERS AND RECORD DATE FOR FINAL DIVIDEND Notice of Dividend Amount	2026-04-29	English
Next Day Disclosure Return Transaction in Own Shares	2026-04-28	English
2025 Annual Report Annual Report FY 2025	2026-04-27	English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-02	English
GRANT OF OPTIONS Share Issue/Capital Change	2026-04-01	English
Final Dividend for the year ended 31 December 2025 Notice of Dividend Amount	2026-03-25	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-03-25	English
VOLUNTARY ANNOUNCEMENT - APOLLO Dream Rapamycin Target Eluting Stent System Granted FDA Breakthrough Device Designation Regulatory Filings	2026-03-18	English
DATE OF BOARD MEETING Regulatory Filings	2026-03-13	English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-05	English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-04	English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-06	English